Concepedia

Sean Lilienfeld

SL

14

Publications

3.1K

Citations

13

H-Index

2000

Active since

Affiliations

Janssen (United States)(Current)

Helsinki University Hospital

Technical University of Munich

King's College Hospital

Victoria Hospital

Sean Lilienfeld is an author at Janssen (United States) specializing in medicine, neurology, and alzheimer's disease.

Top concepts

Publications per year

2000–2019

14

Publications

14

A 5-month, randomized, placebo-controlled trial of galantamine in AD

Pierre N. Tariot, Paul R. Solomon, Julie Morris et al. · Neurology · 2000 · 918 citations

Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial

Timo Erkinjuntti, Alexander Kurz, Serge Gauthier et al. · The Lancet · 2002 · 759 citations

, , +11

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial

G K Wilcock, Sean Lilienfeld, E. Gaens · BMJ · 2000 · 622 citations · Full text

A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimer???s Disease

Gordon Wilcock, Ian Howe, Hilary Coles et al. · Drugs & Aging · 2003 · 212 citations

, , +13

Stroke Treatment Academic Industry Roundtable X

Sean I. Savitz, Jean‐Claude Baron, Marc Fisher et al. · Stroke · 2019 · 183 citations

, , +10

Rows per page

1–5 of 14